資訊洞見

Deacons advises on HK$3,386 million open offer of shares by Hua Han Bio-Pharmaceutical Holdings Limited

Deacons recently represented Haitong International Securities Company Limited as underwriter in relation to the HK$3,386 million open offer of shares by Hua Han Bio-Pharmaceutical Holdings Limited.

Hua Han Bio-Pharmaceutical Holdings Limited is an investment holding company. It manufactures and sells pharmaceutical, medicinal healthcare and biopharmaceutical products.

The team was led by partner Kelvan Cheung who was supported by associate Michelle Leung.

相關業務及行業:

生命科學與醫療保健

Portfolio Builder

Select the 本行服務 that you would like to download or add to the portfolio

Download    Add to portfolio   
Portfolio
職務 Type CV 電郵

Remove All

Download


Click here to share this shortlist.
(It will expire after 30 days.)